Showing results (1231-1240 of 1,759) with videos related to

Sort By:
Pageof 176
Contrast Media & Molecular Imaging|August 7, 2010
Dynamic contrast-enhanced computed tomography for the quantification of tumor response to vasoactive agents in a rat tumor model: preliminary resultsRachel E Pollard, Richard F Larson
Contrast Media & Molecular Imaging|August 7, 2010
Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™Benjamin Addicott, Melissa Willman, Jose Rodriguez, et al.
Contrast Media & Molecular Imaging|September 3, 2010
Multimodality imaging techniquesLuis Martí-Bonmatí, Ramón Sopena, Paula Bartumeus, et al.
Contrast Media & Molecular Imaging|September 3, 2010
A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imagingMatti M van Schooneveld, David P Cormode, Rolf Koole, et al.
Contrast Media & Molecular Imaging|July 16, 2008
Kidney volume quantification using contrast-enhanced in vivo X-ray micro-CT in miceM Almajdub, L Magnier, L Juillard, et al.
Contrast Media & Molecular Imaging|March 11, 2009
MR determination of glomerular filtration rate in subjects with solitary kidneys in comparison to clinical standards of renal function: feasibility and preliminary reportRichard W Katzberg, Michael H Buonocore, Roger Low, et al.
Contrast Media & Molecular Imaging|January 13, 2009
Internalization of annexin A5-functionalized iron oxide particles by apoptotic Jurkat cellsGeralda A F van Tilborg, Tessa Geelen, Hans Duimel, et al.
Contrast Media & Molecular Imaging|February 5, 2009
Morphology, binding behavior and MR-properties of paramagnetic collagen-binding liposomesH M H F Sanders, G J Strijkers, W J M Mulder, et al.
Contrast Media & Molecular Imaging|October 26, 2010
Iron oxide particles covered with hexapeptides targeted at phosphatidylserine as MR biomarkers of tumor cell deathK A Radermacher, S Boutry, S Laurent, et al.
Contrast Media & Molecular Imaging|October 26, 2010
Imaging monocytes with iron oxide nanoparticles targeted towards the monocyte integrin MAC-1 (CD11b/CD18) does not result in improved atherosclerotic plaque detection by in vivo MRIC von zur Muhlen, A Fink-Petri, J Salaklang, et al.
Pageof 176